SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001176256-23-000047
Filing Date
2023-03-16
Accepted
2023-03-16 07:08:56
Documents
143
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF imv-20221231.htm   iXBRL 20-F 2131193
2 ARTICLES OF INCORPORATION AND BY-LAWS OF IMV INC. exhibit1-1.htm EX-1.1 188109
3 FUNDING CERTIFICATE DATED JUNE 21, 2022 exhibit4-1-1.htm EX-4.1-1 33776
4 LICENSE AGREEMENT DATED JULY 12, 2010 exhibit4-2.htm EX-4.2 194718
5 SECURITIES PURCHASE AGREEMENT DATED DECEMBER 16, 2022 exhibit4-3.htm EX-4.3 233728
6 LEASE DATED JULY 26, 2021 exhibit4-5.htm EX-4.5 38462
7 LEASE DATED FEBRUARY 8, 2018 exhibit4-6.htm EX-4.6 1103044
8 EMPLOYMENT CONTRACT, EFFECTIVE JANUARY 1, 2022 exhibit4-7.htm EX-4.7 169343
9 EMPLOYMENT CONTRACT, EFFECTIVE SEPTEMBER 15, 2022 exhibit4-8.htm EX-4.8 78331
10 EMPLOYMENT CONTRACT, EFFECTIVE JUNE 14, 2021 exhibit4-9.htm EX-4.9 144959
11 FORM OF DEFERRED SHARE UNIT AGREEMENT exhibit4-10-1.htm EX-4.10-1 10033
12 SUBSIDIARIES OF IMV INC. exhibit8-1.htm EX-8.1 1423
13 CODE OF CONDUCT exhibit11-1.htm EX-11.1 27300
14 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit12-1.htm EX-12.1 6261
15 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER exhibit12-2.htm EX-12.2 6228
16 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO exhibit13-1.htm EX-13.1 2561
17 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO exhibit13-2.htm EX-13.2 2570
18 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit15-1.htm EX-15.1 1688
19 MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2022 exhibit15-2.htm EX-15.2 330750
20 exhibit1-1x1x1.jpg GRAPHIC 18231
21 exhibit1-1x1x2.jpg GRAPHIC 8112
22 exhibit1-1x1x3.jpg GRAPHIC 29135
23 exhibit11-1x1x1.jpg GRAPHIC 26249
24 exhibit15-1x1x1.jpg GRAPHIC 4826
25 fin_001.jpg GRAPHIC 16800
26 fin_002.jpg GRAPHIC 5010
27 image_001.jpg GRAPHIC 10680
28 image_002.jpg GRAPHIC 24162
29 image_003.jpg GRAPHIC 28123
30 image_004.jpg GRAPHIC 19814
31 la_001.jpg GRAPHIC 9290
32 m_001.jpg GRAPHIC 3991
33 m_002.jpg GRAPHIC 1870
34 m_003.jpg GRAPHIC 35891
35 m_004.jpg GRAPHIC 6442
36 m_005.jpg GRAPHIC 1556
37 m_006.jpg GRAPHIC 88946
38 m_007.jpg GRAPHIC 45159
39 m_008.jpg GRAPHIC 42882
40 m_009.jpg GRAPHIC 49471
41 m_010.jpg GRAPHIC 7450
42 mda_001.jpg GRAPHIC 4071
43 mda_002.jpg GRAPHIC 24812
44 mda_003.jpg GRAPHIC 28123
45 mda_004.jpg GRAPHIC 19814
46 mda_005.jpg GRAPHIC 67201
  Complete submission text file 0001176256-23-000047.txt   12312779

Data Files

Seq Description Document Type Size
47 imv-20221231.xsd EX-101.SCH 137039
48 imv-20221231_cal.xml EX-101.CAL 26930
49 imv-20221231_def.xml EX-101.DEF 329612
50 imv-20221231_lab.xml EX-101.LAB 745254
51 imv-20221231_pre.xml EX-101.PRE 349539
137 EXTRACTED XBRL INSTANCE DOCUMENT imv-20221231_htm.xml XML 1153097
Mailing Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4
Business Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38480 | Film No.: 23737108
SIC: 2834 Pharmaceutical Preparations